Market Overview

UPDATE: Morgan Stanley Upgrades Walgreen to Equal-weight; Express Overhang Removed

Related WAG
Top 4 NYSE Stocks In The Drug Stores Industry With The Highest ROE
Walgreen Co. Or CVS Caremark: Which Would You Rather?
Cavuto: Call for Consistent Press Standards (Fox Business)

Morgan Stanley raised its rating on Walgreen (NYSE: WAG) from Overweight to Equalweight and removed its previous price target of $31.

Morgan Stanley noted, "The Express Scripts dispute is over, but focus now turns to growth prospects for Alliance Boots and related Europe risk. We still see an unsettled US EPS backdrop (couponing to win back Express customers, weak front-end and new Express-Medco contract margins)."

Walgreen closed at $35.52 on Thursday.

Posted-In: Morgan StanleyAnalyst Color Upgrades Price Target Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (WAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters